ODE PHARMA

📍 Jerusalem, Israel🗓 Founded 2020👥 1 employees💰 Last funded Nov 2020
Pharmaceutical Manufacturing🌐 odepharma.com
Website LinkedIn
ODE PHARMA is a biotechnology company specializing in microbiome-based medicine. Our breakthrough treatments target breathing and lung disorders, harnessing the bodys natural systems to restore damaged lung cells and enhance respiratory health. Our technology revolves around the crucial role of mitochondria in maintaining overall health and the integrity of epithelial tissues. With promising results in COVID-19 and asthma patients, we are dedicated to addressing the rising global demand for effective and natural respiratory solutions.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
1
Frequently asked questions
Who invested in ODE PHARMA?
ODE PHARMA has 1 investors on record on gritt.io, including 1 early-stage backers.
When did ODE PHARMA last raise funding?
The most recent investment in ODE PHARMA recorded on gritt.io was in November 2020.
When was ODE PHARMA founded?
ODE PHARMA was founded in 2020.
What industry is ODE PHARMA in?
ODE PHARMA operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is ODE PHARMA based?
ODE PHARMA is headquartered in Jerusalem, Israel.